Related Experiment Videos
Clinical radiofrequency hyperthermia: a review
National Cancer Institute Monograph
|June 1, 1982
Summary
Localized radiofrequency (RF) hyperthermia shows promise as a cancer treatment. Effective heating of tumors at 42°C or higher, especially with combined therapies, may significantly improve cancer treatment outcomes.
Area of Science:
- Oncology
- Medical Physics
- Biomedical Engineering
Background:
- Radiofrequency (RF) hyperthermia is an emerging cancer therapy modality.
- Investigating its use as a standalone treatment or in conjunction with radiation and chemotherapy.
- Comparing standard capacitive/inductive heating with novel magnetrode magnetic-loop induction for safety and efficacy.
Purpose of the Study:
- To evaluate the safety and efficacy of localized RF hyperthermia in cancer treatment.
- To determine optimal treatment parameters for tumoricidal effects.
- To assess the potential synergistic effects of hyperthermia with conventional therapies.
Main Methods:
- Clinical trials comparing different RF heating techniques (capacitive, inductive, magnetrode).
- Administration of localized RF hyperthermia to superficial and deep visceral tumors.
- Monitoring tumor temperatures and treatment outcomes.
Main Results:
- Localized RF hyperthermia can be safely administered to various tumors with appropriate equipment.
- Temperatures of 42°C or higher are tumoricidal, with higher temperatures and longer/multiple treatments being more beneficial.
- Heating effectiveness is independent of tumor histology but may depend on size and blood flow.
- Hyperthermia demonstrates synergistic or additive effects when combined with radiation therapy and chemotherapy.
Conclusions:
- Localized RF hyperthermia is a safe and potentially effective cancer treatment.
- Optimal treatment involves achieving temperatures of 42°C or higher.
- Combined modality treatments show enhanced therapeutic benefits.
- RF hyperthermia is poised to become a valuable addition to cancer treatment strategies.